The people we need for our research aren’t signing up to take surveys in their spare time.”Ĭascade turned to NewtonX to overcome these limitations. It was in that moment, Swigart recalls, that Cascade realized “the whole panel model is broken.
This led to rampant fraud - and worthless data.
#CASCADE INSIGHTS HOW TO#
That provider in turn fielded the survey to a pre-registered panel of unqualified, poorly paid respondents who knew how to beat screeners. Looking into it, Cascade discovered that the panel company had outsourced the survey to a third-party provider. A head-scratching result came back: Respondents listed Salesforce - the world’s leading CRM - in 4th place, well below some more-niche CRMs. Not long ago, Cascade Insights tasked their panel company with fielding a survey to learn which customer-relationship management (CRM) systems the technology industry relied most on. A custom recruiting methodology leads to decision-quality data Eder and Swigart discussed why AI-powered platforms like NewtonX’s Knowledge Graph are essential to gaining competitive intelligence and generating reliable data that will help businesses excel.ġ. But when so many B2B market research companies rely on pre-determined panels of experts, where do you go for the custom findings that will be responsive to the specific needs of your business? In a recent conversation, Sascha Eder, the CEO of NewtonX - a leader in custom B2B research - spoke with Scott Swigart, the CTO of the market research firm Cascade Insights, specializing in B2B tech research. Mini-Reviews in Medicinal Chemistry Plants vs.Enterprise leaders know that they need reliable insights from professionals to guide their decision-making. Outcome Measures Following Sonodynamic Photodynamic Therapy – A Case SeriesĬurrent Drug Therapy Iron Chelators as Anti-Neoplastic Agents: Current Developments and Promise of the PIH Class of ChelatorsĬurrent Medicinal Chemistry The Prevention of Preterm Labour - Corticotropin Releasing Hormone Type 1 Receptors as a Target for Drug Design and Development Finally, approved reversal agents that aid in maintaining blood haemostasis by using these commercial drugs will also be discussed. Then, we will review the current state of the synthesis of novel direct FXa inhibitors along with their mechanisms of action. In this review, we will first describe the molecular features of this fundamental protein in order to understand its mechanism of action, an essential background for the design of novel inhibitors by means of synthetic organic chemistry or using peptides obtained from recombinant methodologies. Therefore, FXa is an attractive target for the development of new anticoagulant agents. Keywords: Coagulation cascade, anticoagulants, FXa, synthetic inhibitors, direct FXa inhibitors, FXa reversal agents.Ībstract: Factor Xa (FXa) plays a key role in haemostasis, it is a central part of the blood coagulation cascade which catalyzes the production of thrombin and leads to clot formation and wound closure.
0 kommentar(er)
